Positive Results In Study of Novartis Drug Afinitor (NVS) - Novartis (NYSE:NVS)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Novartis AG (NYSE: NVS) reported after the close today, November 3rd The New England Journal of Medicine published a study which found patients taking Afinitor tablets saw a decrease in the size of their subependymal giant cell astrocytoma. Astrocytoma's are a benign brain tumor associated with TB 1 and 2. The company stated during a presentation at the 46th annual American Society of Clinical Oncology annual meeting this is the first study to show a beneficial use of the drug in patients.Day's Range: 57.90 - 58.6252wk Range: 43.48 - 60.07

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!